Aribiolab: 주요사항보고서(유상증자결정)
AI reading
★★★★ Bullish · Rights offering
전략적 협력을 위한 제3자배정 유상증자 및 1년 보호예수
Key figures: 신주 5,196,304주, 발행가액 3,464원
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
Other filings by Aribiolab
- 09.22 ★★ [Amended] Report on Material Matters (Decision to Issue Convertible Bonds)
- 09.16 ★★ Large Shareholding Report (General)
- 09.16 ★★ [Amendment] Material Fact Report (Decision on Paid-in Capital Increase)
- 09.14 ★★★ 운영자금 확보를 위한 30억 규모의 전환사채 발행 결정
- 09.09 ★★ [Amended] Execution of share pledge agreement involving change in largest shareholder
- 09.09 ★★★ 운영자금 확보를 위한 70억 규모의 전환사채(CB) 발행 결정
For information only. Not investment advice.